Genus PLC
LSE:GNS

Watchlist Manager
Genus PLC Logo
Genus PLC
LSE:GNS
Watchlist
Price: 1 718 GBX 4.5% Market Closed
Market Cap: 1.1B GBX
Have any thoughts about
Genus PLC?
Write Note

Intrinsic Value

The intrinsic value of one GNS stock under the Base Case scenario is 1 949.22 GBX. Compared to the current market price of 1 718 GBX, Genus PLC is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GNS Intrinsic Value
1 949.22 GBX
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genus PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GNS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GNS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Genus PLC

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Genus PLC

Provide an overview of the primary business activities
of Genus PLC.

What unique competitive advantages
does Genus PLC hold over its rivals?

What risks and challenges
does Genus PLC face in the near future?

Summarize the latest earnings call
of Genus PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genus PLC.

Provide P/S
for Genus PLC.

Provide P/E
for Genus PLC.

Provide P/OCF
for Genus PLC.

Provide P/FCFE
for Genus PLC.

Provide P/B
for Genus PLC.

Provide EV/S
for Genus PLC.

Provide EV/GP
for Genus PLC.

Provide EV/EBITDA
for Genus PLC.

Provide EV/EBIT
for Genus PLC.

Provide EV/OCF
for Genus PLC.

Provide EV/FCFF
for Genus PLC.

Provide EV/IC
for Genus PLC.

Show me price targets
for Genus PLC made by professional analysts.

What are the Revenue projections
for Genus PLC?

How accurate were the past Revenue estimates
for Genus PLC?

What are the Net Income projections
for Genus PLC?

How accurate were the past Net Income estimates
for Genus PLC?

What are the EPS projections
for Genus PLC?

How accurate were the past EPS estimates
for Genus PLC?

What are the EBIT projections
for Genus PLC?

How accurate were the past EBIT estimates
for Genus PLC?

Compare the revenue forecasts
for Genus PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genus PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genus PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genus PLC compared to its peers.

Compare the P/E ratios
of Genus PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Genus PLC with its peers.

Analyze the financial leverage
of Genus PLC compared to its main competitors.

Show all profitability ratios
for Genus PLC.

Provide ROE
for Genus PLC.

Provide ROA
for Genus PLC.

Provide ROIC
for Genus PLC.

Provide ROCE
for Genus PLC.

Provide Gross Margin
for Genus PLC.

Provide Operating Margin
for Genus PLC.

Provide Net Margin
for Genus PLC.

Provide FCF Margin
for Genus PLC.

Show all solvency ratios
for Genus PLC.

Provide D/E Ratio
for Genus PLC.

Provide D/A Ratio
for Genus PLC.

Provide Interest Coverage Ratio
for Genus PLC.

Provide Altman Z-Score Ratio
for Genus PLC.

Provide Quick Ratio
for Genus PLC.

Provide Current Ratio
for Genus PLC.

Provide Cash Ratio
for Genus PLC.

What is the historical Revenue growth
over the last 5 years for Genus PLC?

What is the historical Net Income growth
over the last 5 years for Genus PLC?

What is the current Free Cash Flow
of Genus PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genus PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genus PLC

Current Assets 271.1m
Cash & Short-Term Investments 42.5m
Receivables 137.3m
Other Current Assets 91.3m
Non-Current Assets 757.8m
Long-Term Investments 61.6m
PP&E 479.4m
Intangibles 175.7m
Other Non-Current Assets 41.1m
Current Liabilities 150.6m
Accounts Payable 123.2m
Other Current Liabilities 27.4m
Non-Current Liabilities 330.1m
Long-Term Debt 272.3m
Other Non-Current Liabilities 57.8m
Efficiency

Earnings Waterfall
Genus PLC

Revenue
668.8m GBP
Operating Expenses
-614.6m GBP
Operating Income
54.2m GBP
Other Expenses
-46.3m GBP
Net Income
7.9m GBP

Free Cash Flow Analysis
Genus PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

The company delivered solid yearly results, with actual currency-adjusted operating profit rising by 10%. While adjusted profit before tax remained flat at ÂŁ71.5 million, R&D investments grew, led by a 66% increase in gene editing costs as regulatory approval for a disease-resistant pig looms near. This increased spend dampened operating profit margins to 12.4%. Looking ahead to FY 2024, the company anticipates meeting medium-term profit growth targets in constant currency, despite expecting only modest profit before tax growth due to currency and interest rate challenges. An exciting milestone awaiting investors is the potential FDA approval of their PRRSv resistant pig.

What is Earnings Call?
Fundamental Scores

GNS Profitability Score
Profitability Due Diligence

Genus PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Free Cash Flow
Positive Operating Income
45/100
Profitability
Score

Genus PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

GNS Solvency Score
Solvency Due Diligence

Genus PLC's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
45/100
Solvency
Score

Genus PLC's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GNS Price Targets Summary
Genus PLC

Wall Street analysts forecast GNS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNS is 2 600.71 GBX with a low forecast of 2 070.5 GBX and a high forecast of 3 255 GBX.

Lowest
Price Target
2 070.5 GBX
21% Upside
Average
Price Target
2 600.71 GBX
51% Upside
Highest
Price Target
3 255 GBX
89% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GNS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GNS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Genus PLC Logo
Genus PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

1.1B GBP

Dividend Yield

1.86%

Description

Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire and currently employs 3,096 full-time employees. The company went IPO on 2000-07-06. The firm provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company’s operating segments includes Genus PIC, Genus ABS and Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. The firm's development activities include developing and maintaining its porcine genetic nucleus herd and bovine pre-stud herds. The firm operates approximately around 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.

Contact

HAMPSHIRE
Basingstoke
Matrix House, Basing View
+441256347100.0
www.genusplc.com

IPO

2000-07-06

Employees

3 096

Officers

Chief Executive Officer & Director
Mr. Jorgen Kokke
CFO & Executive Director
Ms. Alison Jane Henriksen ACA
Chief Operating Officer
Dr. Matt Culbertson
Head of R&D and Chief Scientific Officer
Dr. Elena Rice
Group General Counsel & Company Secretary
Mr. Daniel William David Hartley
Group Human Resources Director
Ms. Angelle R. Rosata
Show More
Global Head of Beef & Aqua
Mr. Jerry Thompson
Head of ABS EMEA
Andrew Thompson
Chief Operating Officer of Genus ABS
Mr. Jim Low
Group Financial Controller
Ms. Janet Duane
Show Less

See Also

Discover More
What is the Intrinsic Value of one GNS stock?

The intrinsic value of one GNS stock under the Base Case scenario is 1 949.22 GBX.

Is GNS stock undervalued or overvalued?

Compared to the current market price of 1 718 GBX, Genus PLC is Undervalued by 12%.

Back to Top